{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:10:15Z","timestamp":1793106615386,"version":"4.5.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T00:00:00Z","timestamp":1418774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s12035-014-9053-6","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T02:21:40Z","timestamp":1418696500000},"page":"648-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":466,"title":["Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer\u2019s Disease: Understanding the Therapeutics Strategies"],"prefix":"10.1007","volume":"53","author":[{"given":"Pradip K.","family":"Kamat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivika","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Swarnkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santoshkumar","family":"Tota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandishwar","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"key":"9053_CR1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/jnnp.2006.100529","volume":"78","author":"DR Gustafson","year":"2007","unstructured":"Gustafson DR, Skoog I, Rosengren L, Zetterberg H, Blennow K (2007) Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women. J Neurol Neurosurg Psychiatry 78:461\u2013464","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9053_CR2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/156720512799361691","volume":"9","author":"Z Wang","year":"2012","unstructured":"Wang Z, Yang L, Zheng H (2012) Role of APP and Abeta in synaptic physiology. Curr Alzheimer Res 9:217\u2013226","journal-title":"Curr Alzheimer Res"},{"key":"9053_CR3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","volume":"31","author":"I Bezprozvanny","year":"2008","unstructured":"Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer\u2019s disease. Trends Neurosci 31:454\u2013463","journal-title":"Trends Neurosci"},{"key":"9053_CR4","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","volume":"282","author":"FG Felice De","year":"2007","unstructured":"De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590\u201311601","journal-title":"J Biol Chem"},{"key":"9053_CR5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pbb.2013.11.035","volume":"117","author":"S Rai","year":"2014","unstructured":"Rai S, Kamat PK, Nath C, Shukla R (2014) Glial activation and post-synaptic neurotoxicity: the key events in streptozotocin (ICV) induced memory impairment in rats. Pharmacol Biochem Behav 117:104\u2013117","journal-title":"Pharmacol Biochem Behav"},{"key":"9053_CR6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","volume":"31","author":"ED Roberson","year":"2011","unstructured":"Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, Wu T, Hamto P, Devidze N, Yu GQ, Palop JJ, Noebels JL, Mucke L (2011) Amyloid-beta\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer\u2019s disease. J Neurosci 31:700\u2013711","journal-title":"J Neurosci"},{"key":"9053_CR7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pbb.2011.08.019","volume":"100","author":"PK Kamat","year":"2012","unstructured":"Kamat PK, Tota S, Shukla R, Ali S, Najmi AK, Nath C (2012) Mitochondrial dysfunction: a crucial event in okadaic acid (ICV) induced memory impairment and apoptotic cell death in rat brain. Pharmacol Biochem Behav 100:311\u2013319","journal-title":"Pharmacol Biochem Behav"},{"key":"9053_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2014.06.012","author":"PK Kamat","year":"2014","unstructured":"Kamat PK, Rai S, Swarnkar S, Shukla R, Nath C (2014) Mechanism of synapse redox stress in okadaic acid (ICV) induced memory impairment: role of NMDA receptor. Neurochem Int. doi: 10.1016\/j.neuint.2014.06.012","journal-title":"Neurochem Int"},{"key":"9053_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2012.08.008","volume":"254","author":"S Rai","year":"2013","unstructured":"Rai S, Kamat PK, Nath C, Shukla R (2013) A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats. J Neuroimmunol 254:1\u20139","journal-title":"J Neuroimmunol"},{"key":"9053_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2013.01.075","volume":"238","author":"PK Kamat","year":"2013","unstructured":"Kamat PK, Rai S, Swarnkar S, Shukla R, Ali S, Najmi AK, Nath C (2013) Okadaic acid-induced tau phosphorylation in rat brain: role of NMDA receptor. Neuroscience 238:97\u2013113","journal-title":"Neuroscience"},{"key":"9053_CR11","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S1357-2725(02)00077-8","volume":"34","author":"DG Nicholls","year":"2002","unstructured":"Nicholls DG (2002) Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease. Int J Biochem Cell Biol 34:1372\u20131381","journal-title":"Int J Biochem Cell Biol"},{"key":"9053_CR12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0169-328X(01)00214-5","volume":"38","author":"AA Farooqui","year":"2001","unstructured":"Farooqui AA, Yi Ong W, Lu XR, Halliwell B, Horrocks LA (2001) Neurochemical consequences of kainate-induced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A(2) inhibitors. Brain Res Brain Res Rev 38:61\u201378","journal-title":"Brain Res Brain Res Rev"},{"issue":"1","key":"9053_CR13","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9053_CR14","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1523\/JNEUROSCI.3269-07.2007","volume":"27","author":"KF Bell","year":"2007","unstructured":"Bell KF, Bennett DA, Cuello AC (2007) Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J Neurosci 27:10810\u201310817","journal-title":"J Neurosci"},{"key":"9053_CR15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-009-0536-x","volume":"118","author":"T Arendt","year":"2009","unstructured":"Arendt T (2009) Synaptic degeneration in Alzheimer\u2019s disease. Acta Neuropathol 118:167\u2013179","journal-title":"Acta Neuropathol"},{"key":"9053_CR16","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrn3353","volume":"13","author":"LN Cooper","year":"2011","unstructured":"Cooper LN, Bear MF (2011) The BCM theory of synapse modification at 30: interaction of theory with experiment. Nat Rev Neurosci 13:798\u2013810","journal-title":"Nat Rev Neurosci"},{"key":"9053_CR17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Alzheimer\u2019s disease is a synaptic failure. Science 298:789\u2013791","journal-title":"Science"},{"key":"9053_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12035-011-8190-4","volume":"44","author":"F Fetterolf","year":"2011","unstructured":"Fetterolf F, Foster KA (2011) Regulation of long-term plasticity induction by the channel and C-terminal domains of GluN2 subunits. Mol Neurobiol 44:71\u201382","journal-title":"Mol Neurobiol"},{"key":"9053_CR19","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1042\/BST0371369","volume":"37","author":"CG Lau","year":"2009","unstructured":"Lau CG, Takeuchi K, Rodenas-Ruano A, Takayasu Y, Murphy J, Bennett MV, Zukin RS (2009) Regulation of NMDA receptor Ca2+ signalling and synaptic plasticity. Biochem Soc Trans 37:1369\u20131374","journal-title":"Biochem Soc Trans"},{"key":"9053_CR20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2009.10.064","volume":"1309","author":"PK Kamat","year":"2010","unstructured":"Kamat PK, Tota S, Saxena G, Shukla R, Nath C (2010) Okadaic acid (ICV) induced memory impairment in rats: a suitable experimental model to test anti-dementia activity. Brain Res 1309:66\u201374","journal-title":"Brain Res"},{"key":"9053_CR21","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0531-5565(02)00175-4","volume":"37","author":"W Droge","year":"2002","unstructured":"Droge W (2002) Aging-related changes in the thiol\/disulfide redox state: implications for the use of thiol antioxidants. Exp Gerontol 37:1333\u20131345","journal-title":"Exp Gerontol"},{"key":"9053_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","volume":"82","author":"W Droge","year":"2002","unstructured":"Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47\u201395","journal-title":"Physiol Rev"},{"key":"9053_CR23","doi-asserted-by":"crossref","first-page":"36187","DOI":"10.1074\/jbc.M607444200","volume":"281","author":"I Kissova","year":"2006","unstructured":"Kissova I, Plamondon LT, Brisson L, Priault M, Renouf V, Schaeffer J, Camougrand N, Manon S (2006) Evaluation of the roles of apoptosis, autophagy, and mitophagy in the loss of plating efficiency induced by Bax expression in yeast. J Biol Chem 281:36187\u201336197","journal-title":"J Biol Chem"},{"key":"9053_CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0301-0082(00)00044-7","volume":"64","author":"H Prast","year":"2001","unstructured":"Prast H, Philippu A (2001) Nitric oxide as modulator of neuronal function. Prog Neurobiol 64:51\u201368","journal-title":"Prog Neurobiol"},{"key":"9053_CR25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0891-5849(02)01184-X","volume":"3","author":"D Liu","year":"2003","unstructured":"Liu D, Liu J, Sun D, Alcock NW, Wen J (2003) Spinal cord injury increases iron levels: catalytic production of hydroxyl radicals. Free Radic Biol Med 3:64\u201371","journal-title":"Free Radic Biol Med"},{"key":"9053_CR26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/155005941104200309","volume":"42","author":"R Sachdeva","year":"2011","unstructured":"Sachdeva R, Babbar R, Puri V, Agarwal S, Krishana B (2011) Correlation between cognitive functions and nitric oxide levels in patients with dementia. Clin EEG Neurosci 42:190\u2013194","journal-title":"Clin EEG Neurosci"},{"key":"9053_CR27","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1517\/14728222.2011.557363","volume":"15","author":"K Chopra","year":"2011","unstructured":"Chopra K, Misra S, Kuhad A (2011) Neurobiological aspects of Alzheimer\u2019s disease. Expert Opin Ther Targets 15:535\u2013555","journal-title":"Expert Opin Ther Targets"},{"key":"9053_CR28","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1152\/jn.00661.2005","volume":"94","author":"JH Shin","year":"2005","unstructured":"Shin JH, Linden DJ (2005) An NMDA receptor\/nitric oxide cascade is involved in cerebellar LTD but is not localized to the parallel fiber terminal. J Neurophysiol 94:4281\u20134289","journal-title":"J Neurophysiol"},{"key":"9053_CR29","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1002\/jnr.21290","volume":"85","author":"DG Nicholls","year":"2007","unstructured":"Nicholls DG, Johnson-Cadwell L, Vesce S, Jekabsons M, Yadava N (2007) Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity. J Neurosci Res 85:3206\u20133212","journal-title":"J Neurosci Res"},{"key":"9053_CR30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/156720506778249515","volume":"3","author":"KP Loh","year":"2006","unstructured":"Loh KP, Huang SH, De Silva R, Tan BK, Zhu YZ (2006) Oxidative stress: apoptosis in neuronal injury. Curr Alzheimer Res 3:327\u2013337","journal-title":"Curr Alzheimer Res"},{"key":"9053_CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/bbrc.2001.4306","volume":"281","author":"E Engidawork","year":"2001","unstructured":"Engidawork E, Gulesserian T, Yoo BC, Cairns N, Lubec G (2001) Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer\u2019s disease. Biochem Biophys Res Commun 281:84\u201393","journal-title":"Biochem Biophys Res Commun"},{"key":"9053_CR32","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1523\/JNEUROSCI.20-10-03641.2000","volume":"20","author":"GW Glazner","year":"2000","unstructured":"Glazner GW, Chan SL, Lu C, Mattson MP (2000) Caspase-mediated degradation of AMPA receptor subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis. J Neurosci 20:3641\u20133649","journal-title":"J Neurosci"},{"key":"9053_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2000.0740001.x","volume":"74","author":"PS Sastry","year":"2000","unstructured":"Sastry PS, Rao KS (2000) Apoptosis and the nervous system. J Neurochem 74:1\u201320","journal-title":"J Neurochem"},{"key":"9053_CR34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/(SICI)1097-4547(19991001)58:1<152::AID-JNR15>3.0.CO;2-V","volume":"58","author":"MP Mattson","year":"1999","unstructured":"Mattson MP, Duan W (1999) \u201cApoptotic\u201d biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders. J Neurosci Res 58:152\u2013166","journal-title":"J Neurosci Res"},{"key":"9053_CR35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nn.2709","volume":"14","author":"M D\u2019Amelio","year":"2011","unstructured":"D\u2019Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A, Diamantini A, De Zio D, Carrara P, Battistini L, Moreno S, Bacci A, Ammassari-Teule M, Marie H, Cecconi F (2011) Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer\u2019s disease. Nat Neurosci 14:69\u201376","journal-title":"Nat Neurosci"},{"key":"9053_CR36","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2353\/ajpath.2008.080434","volume":"173","author":"N Louneva","year":"2008","unstructured":"Louneva N, Cohen JW, Han LY, Talbot K, Wilson RS, Bennett DA, Trojanowski JQ, Arnold SE (2008) Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer\u2019s disease. Am J Pathol 173:1488\u20131495","journal-title":"Am J Pathol"},{"key":"9053_CR37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nn.2785","volume":"14","author":"J Jo","year":"2011","unstructured":"Jo J, Whitcomb DJ, Olsen KM, Kerrigan TL, Lo SC, Bru-Mercier G, Dickinson B, Scullion S, Sheng M, Collingridge G, Cho K (2011) Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta. Nat Neurosci 14:545\u2013547","journal-title":"Nat Neurosci"},{"key":"9053_CR38","doi-asserted-by":"crossref","first-page":"17042","DOI":"10.1523\/JNEUROSCI.1836-13.2013","volume":"33","author":"H Xie","year":"2013","unstructured":"Xie H, Guan J, Borrelli LA, Xu J, Serrano-Pozo A, Bacskai BJ (2013) Mitochondrial alterations near amyloid plaques in an Alzheimer\u2019s disease mouse model. J Neurosci 33:17042\u201317051","journal-title":"J Neurosci"},{"key":"9053_CR39","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bbabio.2009.02.005","volume":"1787","author":"R Yamaguchi","year":"2009","unstructured":"Yamaguchi R, Perkins G (2009) Dynamics of mitochondrial structure during apoptosis and the enigma of Opa1. Biochim Biophys Acta 1787:963\u2013972","journal-title":"Biochim Biophys Acta"},{"key":"9053_CR40","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","volume":"21","author":"K Hirai","year":"2001","unstructured":"Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer\u2019s disease. J Neurosci 21:3017\u20133023","journal-title":"J Neurosci"},{"key":"9053_CR41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.neuint.2004.03.003","volume":"45","author":"SM Cardoso","year":"2004","unstructured":"Cardoso SM, Rego AC, Penacho N, Oliveira CR (2004) Apoptotic cell death induced by hydrogen peroxide in NT2 parental and mitochondrial DNA depleted cells. Neurochem Int 45:693\u2013698","journal-title":"Neurochem Int"},{"key":"9053_CR42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44\u201384","journal-title":"Int J Biochem Cell Biol"},{"key":"9053_CR43","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jcb.21666","volume":"104","author":"YQ Zhang","year":"2008","unstructured":"Zhang YQ, Herman B (2008) Expression and modification of ARC (apoptosis repressor with a CARD domain) is distinctly regulated by oxidative stress in cancer cells. J Cell Biochem 104:818\u2013825","journal-title":"J Cell Biochem"},{"key":"9053_CR44","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1002\/jnr.22152","volume":"87","author":"XD Zhang","year":"2009","unstructured":"Zhang XD, Wang Y, Wu JC, Lin F, Han R, Han F, Fukunaga K, Qin ZH (2009) Down-regulation of Bcl-2 enhances autophagy activation and cell death induced by mitochondrial dysfunction in rat striatum. J Neurosci Res 87:3600\u20133610","journal-title":"J Neurosci Res"},{"key":"9053_CR45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbadis.2009.10.007","volume":"1802","author":"PI Moreira","year":"2009","unstructured":"Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA (2009) Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 1802:212\u2013220","journal-title":"Biochim Biophys Acta"},{"key":"9053_CR46","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1440-1681.2011.05609.x","volume":"38","author":"H Cui","year":"2011","unstructured":"Cui H, Chen B, Chicoine LG, Nelin LD (2011) Overexpression of cationic amino acid transporter-1 increases nitric oxide production in hypoxic human pulmonary microvascular endothelial cells. Clin Exp Pharmacol Physiol 38:796\u2013803","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9053_CR47","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1096\/fj.11-186650","volume":"25","author":"M Dumont","year":"2011","unstructured":"Dumont M, Stack C, Elipenahli C, Jainuddin S, Gerges M, Starkova NN, Yang L, Starkov AA, Beal F (2011) Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice. FASEB J 25:4063\u20134072","journal-title":"FASEB J"},{"key":"9053_CR48","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/en.2006-1154","volume":"148","author":"AK Ho","year":"2007","unstructured":"Ho AK, Terriff DL, Price DM, Wloka MT, Chik CL (2007) The role of inducible repressor proteins in the adrenergic induction of arylalkylamine-N-acetyltransferase and mitogen-activated protein kinase phosphatase-1 in rat pinealocytes. Endocrinology 148:743\u2013751","journal-title":"Endocrinology"},{"key":"9053_CR49","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/ars.2012.4609","volume":"20","author":"X Li","year":"2014","unstructured":"Li X, Schulz E, Wenzel P, Munzel T, Daiber A (2014) Mitochondrial redox signaling: interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxid Redox Signal 20:308\u2013324","journal-title":"Antioxid Redox Signal"},{"key":"9053_CR50","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.bmcl.2004.05.082","volume":"14","author":"A Bhandari","year":"2004","unstructured":"Bhandari A, Holmes CP, Szardenings AK (2004) Alpha, alpha-difluoro-beta-ketophosphonates as potent inhibitors of protein tyrosine phosphatase 1B. Bioorg Med Chem Lett 14:4301\u20134306","journal-title":"Bioorg Med Chem Lett"},{"key":"9053_CR51","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s000180050369","volume":"55","author":"LA Tibbles","year":"1999","unstructured":"Tibbles LA, Woodgett JR (1999) The stress-activated protein kinase pathways. Cell Mol Life Sci 55:1230\u20131254","journal-title":"Cell Mol Life Sci"},{"key":"9053_CR52","doi-asserted-by":"crossref","first-page":"e41536","DOI":"10.1371\/journal.pone.0041536","volume":"7","author":"F Fuentes","year":"2012","unstructured":"Fuentes F, Zimmer D, Atienza M, Schottenfeld J, Penkala I, Bale T, Bence KK, Arregui CO (2012) Protein tyrosine phosphatase PTP1B is involved in hippocampal synapse formation and learning. PLoS ONE 7:e41536","journal-title":"PLoS ONE"},{"key":"9053_CR53","doi-asserted-by":"crossref","first-page":"24977","DOI":"10.1074\/jbc.M000808200","volume":"275","author":"DB Evans","year":"2000","unstructured":"Evans DB, Rank KB, Bhattacharya K, Thomsen DR, Gurney ME, Sharma SK (2000) Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau\u2019s ability to promote microtubule assembly. J Biol Chem 275:24977\u201324983","journal-title":"J Biol Chem"},{"key":"9053_CR54","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1113\/jphysiol.2006.105510","volume":"572","author":"A Ivanov","year":"2006","unstructured":"Ivanov A, Pellegrino C, Rama S, Dumalska I, Salyha Y, Ben-Ari Y, Medina I (2006) Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons. J Physiol 572:789\u2013798","journal-title":"J Physiol"},{"key":"9053_CR55","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1096\/fj.08-107268","volume":"22","author":"F Leveille","year":"2008","unstructured":"Leveille F, El Gaamouch F, Gouix E, Lecocq M, Lobner D, Nicole O, Buisson A (2008) Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J 22:4258\u20134271","journal-title":"FASEB J"},{"key":"9053_CR56","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1523\/JNEUROSCI.4129-11.2012","volume":"32","author":"AM Kaufman","year":"2012","unstructured":"Kaufman AM, Milnerwood AJ, Sepers MD, Coquinco A, She K, Wang L, Lee H, Craig AM, Cynader M, Raymond LA (2012) Opposing roles of synaptic and extrasynaptic NMDA receptor signaling in cocultured striatal and cortical neurons. J Neurosci 32:3992\u20134003","journal-title":"J Neurosci"},{"key":"9053_CR57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuropharm.2013.03.030","volume":"74","author":"Q Zhou","year":"2013","unstructured":"Zhou Q, Sheng M (2013) NMDA receptors in nervous system diseases. Neuropharmacology 74:69\u201375","journal-title":"Neuropharmacology"},{"key":"9053_CR58","first-page":"713","volume":"15","author":"M Ramirez","year":"2009","unstructured":"Ramirez M, Lamas M (2009) NMDA receptor mediates proliferation and CREB phosphorylation in postnatal Muller glia-derived retinal progenitors. Mol Vis 15:713\u2013721","journal-title":"Mol Vis"},{"key":"9053_CR59","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1523\/JNEUROSCI.20-06-02229.2000","volume":"20","author":"SN Gomperts","year":"2000","unstructured":"Gomperts SN, Carroll R, Malenka RC, Nicoll RA (2000) Distinct roles for ionotropic and metabotropic glutamate receptors in the maturation of excitatory synapses. J Neurosci 20:2229\u20132237","journal-title":"J Neurosci"},{"key":"9053_CR60","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.neuron.2007.07.035","volume":"55","author":"C Bellone","year":"2007","unstructured":"Bellone C, Nicoll RA (2007) Rapid bidirectional switching of synaptic NMDA receptors. Neuron 55:779\u2013785","journal-title":"Neuron"},{"key":"9053_CR61","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","volume":"27","author":"GM Shankar","year":"2007","unstructured":"Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866\u20132875","journal-title":"J Neurosci"},{"key":"9053_CR62","doi-asserted-by":"crossref","first-page":"33305","DOI":"10.1074\/jbc.M610390200","volume":"282","author":"M Townsend","year":"2007","unstructured":"Townsend M, Mehta T, Selkoe DJ (2007) Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem 282:33305\u201333312","journal-title":"J Biol Chem"},{"key":"9053_CR63","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1523\/JNEUROSCI.0233-04.2004","volume":"24","author":"Q Wang","year":"2004","unstructured":"Wang Q, Rowan MJ, Anwyl R (2004) Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide. J Neurosci 24:6049\u20136056","journal-title":"J Neurosci"},{"key":"9053_CR64","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1152\/jn.01148.2003","volume":"91","author":"A Kumar","year":"2004","unstructured":"Kumar A, Foster TC (2004) Enhanced long-term potentiation during aging is masked by processes involving intracellular calcium stores. J Neurophysiol 91:2437\u20132444","journal-title":"J Neurophysiol"},{"key":"9053_CR65","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1474-9726.2008.00434.x","volume":"7","author":"LC Reese","year":"2008","unstructured":"Reese LC, Zhang W, Dineley KT, Kayed R, Taglialatela G (2008) Selective induction of calcineurin activity and signaling by oligomeric amyloid beta. Aging Cell 7:824\u2013835","journal-title":"Aging Cell"},{"key":"9053_CR66","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","volume":"423","author":"CJ Phiel","year":"2003","unstructured":"Phiel CJ, Wilson CA, Lee VM, Klein PS (2003) GSK-3alpha regulates production of Alzheimer\u2019s disease amyloid-beta peptides. Nature 423:435\u2013439","journal-title":"Nature"},{"key":"9053_CR67","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"C Hooper","year":"2008","unstructured":"Hooper C, Killick R, Lovestone S (2008) The GSK3 hypothesis of Alzheimer\u2019s disease. J Neurochem 104:1433\u20131439","journal-title":"J Neurochem"},{"key":"9053_CR68","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00001756-200404090-00021","volume":"15","author":"T Hansen","year":"2004","unstructured":"Hansen T, Rehfeld JF, Nielsen FC (2004) GSK-3beta reduces cAMP-induced cholecystokinin gene expression by inhibiting CREB binding. Neuroreport 15:841\u2013845","journal-title":"Neuroreport"},{"key":"9053_CR69","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yexcr.2003.09.026","volume":"293","author":"L Koivisto","year":"2004","unstructured":"Koivisto L, Hakkinen L, Matsumoto K, McCulloch CA, Yamada KM, Larjava H (2004) Glycogen synthase kinase-3 regulates cytoskeleton and translocation of Rac1 in long cellular extensions of human keratinocytes. Exp Cell Res 293:68\u201380","journal-title":"Exp Cell Res"},{"key":"9053_CR70","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1126\/science.1156037","volume":"320","author":"TM Thornton","year":"2008","unstructured":"Thornton TM, Pedraza-Alva G, Deng B, Wood CD, Aronshtam A, Clements JL, Sabio G, Davis RJ, Matthews DE, Doble B, Rincon M (2008) Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 320:667\u2013670","journal-title":"Science"},{"key":"9053_CR71","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2007.01.029","volume":"53","author":"S Peineau","year":"2007","unstructured":"Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E, Bouschet T, Matthews P, Isaac JT, Bortolotto ZA, Wang YT, Collingridge GL (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53:703\u2013717","journal-title":"Neuron"},{"key":"9053_CR72","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.expneurol.2009.09.011","volume":"223","author":"F Hernandez","year":"2010","unstructured":"Hernandez F, Gomez de Barreda E, Fuster-Matanzo A, Lucas JJ, Avila J (2010) GSK3: a possible link between beta amyloid peptide and tau protein. Exp Neurol 223:322\u2013325","journal-title":"Exp Neurol"},{"key":"9053_CR73","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nn.2408","volume":"12","author":"WY Kim","year":"2009","unstructured":"Kim WY, Wang X, Wu Y, Doble BW, Patel S, Woodgett JR, Snider WD (2009) GSK-3 is a master regulator of neural progenitor homeostasis. Nat Neurosci 12:1390\u20131397","journal-title":"Nat Neurosci"},{"key":"9053_CR74","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.neurobiolaging.2007.03.012","volume":"29","author":"GP Liu","year":"2008","unstructured":"Liu GP, Zhang Y, Yao XQ, Zhang CE, Fang J, Wang Q, Wang JZ (2008) Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms. Neurobiol Aging 29:1348\u20131358","journal-title":"Neurobiol Aging"},{"key":"9053_CR75","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1523\/JNEUROSCI.20-07-02567.2000","volume":"20","author":"M Hetman","year":"2000","unstructured":"Hetman M, Cavanaugh JE, Kimelman D, Xia Z (2000) Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci 20:2567\u20132574","journal-title":"J Neurosci"},{"key":"9053_CR76","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1471-4159.2007.05124.x","volume":"105","author":"AI Rojo","year":"2008","unstructured":"Rojo AI, Sagarra MR, Cuadrado A (2008) GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem 105:192\u2013202","journal-title":"J Neurochem"},{"key":"9053_CR77","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jphysparis.2005.12.009","volume":"99","author":"A Jouvenceau","year":"2006","unstructured":"Jouvenceau A, Dutar P (2006) A role for the protein phosphatase 2B in altered hippocampal synaptic plasticity in the aged rat. J Physiol Paris 99:154\u2013161","journal-title":"J Physiol Paris"},{"key":"9053_CR78","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/MN:29:2:167","volume":"29","author":"A Kamsler","year":"2004","unstructured":"Kamsler A, Segal M (2004) Hydrogen peroxide as a diffusible signal molecule in synaptic plasticity. Mol Neurobiol 29:167\u2013178","journal-title":"Mol Neurobiol"},{"key":"9053_CR79","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1523\/JNEUROSCI.23-05-01574.2003","volume":"23","author":"CH Lin","year":"2003","unstructured":"Lin CH, Yeh SH, Leu TH, Chang WC, Wang ST, Gean PW (2003) Identification of calcineurin as a key signal in the extinction of fear memory. J Neurosci 23:1574\u20131579","journal-title":"J Neurosci"},{"key":"9053_CR80","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.arr.2004.05.002","volume":"3","author":"F Serrano","year":"2004","unstructured":"Serrano F, Klann E (2004) Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res Rev 3:431\u2013443","journal-title":"Ageing Res Rev"},{"key":"9053_CR81","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1006\/nlme.2001.4034","volume":"77","author":"QS Chen","year":"2002","unstructured":"Chen QS, Wei WZ, Shimahara T, Xie CW (2002) Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol Learn Mem 77:354\u2013371","journal-title":"Neurobiol Learn Mem"},{"key":"9053_CR82","doi-asserted-by":"crossref","first-page":"38787","DOI":"10.1074\/jbc.M102829200","volume":"276","author":"G Ermak","year":"2001","unstructured":"Ermak G, Morgan TE, Davies KJ (2001) Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer\u2019s disease. J Biol Chem 276:38787\u201338794","journal-title":"J Biol Chem"},{"key":"9053_CR83","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-8108","volume":"8","author":"CN Cook","year":"2005","unstructured":"Cook CN, Hejna MJ, Magnuson DJ, Lee JM (2005) Expression of calcipressin1, an inhibitor of the phosphatase calcineurin, is altered with aging and Alzheimer\u2019s disease. J Alzheimers Dis 8:63\u201373","journal-title":"J Alzheimers Dis"},{"key":"9053_CR84","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1471-4159.2007.04579.x","volume":"102","author":"DJ Koss","year":"2007","unstructured":"Koss DJ, Hindley KP, Riedel G, Platt B (2007) Modulation of hippocampal calcium signalling and plasticity by serine\/threonine protein phosphatases. J Neurochem 102:1009\u20131023","journal-title":"J Neurochem"},{"key":"9053_CR85","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2007.04.057","volume":"1155","author":"Y Lu","year":"2007","unstructured":"Lu Y, Rosenberg PA (2007) NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1\/2A inhibitors. Brain Res 1155:116\u2013124","journal-title":"Brain Res"},{"key":"9053_CR86","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/00023210-200317090-00004","volume":"17","author":"DA Butterfield","year":"2003","unstructured":"Butterfield DA, Pocernich CB (2003) The glutamatergic system and Alzheimer\u2019s disease: therapeutic implications. CNS Drugs 17:641\u2013652","journal-title":"CNS Drugs"},{"key":"9053_CR87","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8:663\u2013672","journal-title":"Nat Rev Neurosci"},{"key":"9053_CR88","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2012","unstructured":"Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan LL, Ashe KH, Liao D (2012) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68:1067\u20131081","journal-title":"Neuron"},{"key":"9053_CR89","doi-asserted-by":"crossref","unstructured":"Li YY, Cui JG, Hill JM, Bhattacharjee S, Zhao Y and Lukiw WJ (2011) Increased expression of miRNA-146a in Alzheimer\u2019s disease transgenic mouse models. Neurosci Lett 487:94\u201398.","DOI":"10.1016\/j.neulet.2010.09.079"},{"key":"9053_CR90","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1113\/jphysiol.2009.178905","volume":"588","author":"RA McKinney","year":"2010","unstructured":"McKinney RA (2010) Excitatory amino acid involvement in dendritic spine formation, maintenance and remodelling. J Physiol 588:107\u2013116","journal-title":"J Physiol"},{"key":"9053_CR91","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1126\/science.290.5495.1364","volume":"290","author":"AE El-Husseini","year":"2000","unstructured":"El-Husseini AE, Schnell E, Chetkovich DM, Nicoll RA, Bredt DS (2000) PSD-95 involvement in maturation of excitatory synapses. Science 290:1364\u20131368","journal-title":"Science"},{"key":"9053_CR92","doi-asserted-by":"crossref","first-page":"32040","DOI":"10.1074\/jbc.M112.401240","volume":"287","author":"S Mondragon-Rodriguez","year":"2012","unstructured":"Mondragon-Rodriguez S, Trillaud-Doppia E, Dudilot A, Bourgeois C, Lauzon M, Leclerc N, Boehm J (2012) Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation. J Biol Chem 287:32040\u201332053","journal-title":"J Biol Chem"},{"key":"9053_CR93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnsyn.2011.00003","volume":"3","author":"H Moreno","year":"2011","unstructured":"Moreno H, Choi S, Yu E, Brusco J, Avila J, Moreira JE, Sugimori M, Llinas RR (2011) Blocking effects of human tau on squid giant synapse transmission and its prevention by T-817 MA. Front Synaptic Neurosci 3:3","journal-title":"Front Synaptic Neurosci"},{"key":"9053_CR94","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, Gotz J (2011) Amyloid-beta and tau\u2014a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci 12:65\u201372","journal-title":"Nat Rev Neurosci"},{"key":"9053_CR95","first-page":"23","volume":"62","author":"L Zhang","year":"2010","unstructured":"Zhang L, Li YH, Meng K, Xie W (2010) The expressions of AMPAR\/GluR2 in hippocampal CA1 area of rats before and after late-phase long-term potentiation reversal. Sheng Li Xue Bao 62:23\u201329","journal-title":"Sheng Li Xue Bao"},{"key":"9053_CR96","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/WNR.0b013e32834b6d5c","volume":"22","author":"H Zhang","year":"2011","unstructured":"Zhang H, Wu CY, Wang W, Harrington MA (2011) Interneuronal synapses formed by motor neurons appear to be glutamatergic. Neuroreport 22:809\u2013813","journal-title":"Neuroreport"},{"key":"9053_CR97","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1523\/JNEUROSCI.1697-04.2004","volume":"24","author":"PV Massey","year":"2004","unstructured":"Massey PV, Johnson BE, Moult PR, Auberson YP, Brown MW, Molnar E, Collingridge GL, Bashir ZI (2004) Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J Neurosci 24:7821\u20137828","journal-title":"J Neurosci"},{"key":"9053_CR98","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000077524","volume":"13","author":"I Perez-Otano","year":"2004","unstructured":"Perez-Otano I, Ehlers MD (2004) Learning from NMDA receptor trafficking: clues to the development and maturation of glutamatergic synapses. Neurosignals 13:175\u2013189","journal-title":"Neurosignals"},{"key":"9053_CR99","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/cne.21289","volume":"501","author":"TM Desilva","year":"2007","unstructured":"Desilva TM, Kinney HC, Borenstein NS, Trachtenberg FL, Irwin N, Volpe JJ, Rosenberg PA (2007) The glutamate transporter EAAT2 is transiently expressed in developing human cerebral white matter. J Comp Neurol 501:879\u2013890","journal-title":"J Comp Neurol"},{"key":"9053_CR100","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1113\/jphysiol.2009.178640","volume":"587","author":"P Ascher","year":"2009","unstructured":"Ascher P, Nowak L (2009) Early biophysics of the NMDA receptor channel. J Physiol 587:4563\u20134564","journal-title":"J Physiol"},{"key":"9053_CR101","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1055\/s-2003-40504","volume":"71","author":"S Bleich","year":"2003","unstructured":"Bleich S, Sperling W, Wiltfang J, Maler JM, Kornhuber J (2003) Excitatory neurotransmission in alcoholism. Fortschr Neurol Psychiatr 71:S36\u2013S44","journal-title":"Fortschr Neurol Psychiatr"},{"key":"9053_CR102","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev.pharmtox.42.082701.145401","volume":"42","author":"JP Adams","year":"2002","unstructured":"Adams JP, Sweatt JD (2002) Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 42:135\u2013163","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9053_CR103","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/107385840200800404","volume":"8","author":"TC Foster","year":"2002","unstructured":"Foster TC, Kumar A (2002) Calcium dysregulation in the aging brain. Neuroscientist 8:297\u2013301","journal-title":"Neuroscientist"},{"key":"9053_CR104","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1126\/science.1162844","volume":"321","author":"MA Busche","year":"2008","unstructured":"Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A, Garaschuk O (2008) Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease. Science 321:1686\u20131689","journal-title":"Science"},{"key":"9053_CR105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuron.2008.06.008","volume":"59","author":"KV Kuchibhotla","year":"2008","unstructured":"Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu HY, Hyman BT, Bacskai BJ (2008) Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59:214\u2013225","journal-title":"Neuron"},{"key":"9053_CR106","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","volume":"8","author":"EM Snyder","year":"2005","unstructured":"Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8:1051\u20131058","journal-title":"Nat Neurosci"},{"key":"9053_CR107","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neuron.2006.10.035","volume":"52","author":"H Hsieh","year":"2006","unstructured":"Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R (2006) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52:831\u2013843","journal-title":"Neuron"},{"key":"9053_CR108","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00726-012-1329-4","volume":"43","author":"MA Souza","year":"2012","unstructured":"Souza MA, Magni DV, Guerra GP, Oliveira MS, Furian AF, Pereira L, Marquez SV, Ferreira J, Fighera MR, Royes LF (2012) Involvement of hippocampal CAMKII\/CREB signaling in the spatial memory retention induced by creatine. Amino Acids 43:2491\u20132503","journal-title":"Amino Acids"},{"key":"9053_CR109","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijdevneu.2012.10.003","volume":"31","author":"G Vierci","year":"2013","unstructured":"Vierci G, Oliveira CS, Perera LR, Bornia N, Leal RB, Rossi FM (2013) CREB is modulated in the mouse superior colliculus in developmental and experimentally-induced models of plasticity. Int J Dev Neurosci 31:46\u201352","journal-title":"Int J Dev Neurosci"},{"key":"9053_CR110","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0092-8674(00)81816-4","volume":"87","author":"H Bito","year":"1996","unstructured":"Bito H, Deisseroth K, Tsien RW (1996) CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87:1203\u20131214","journal-title":"Cell"},{"key":"9053_CR111","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/385260a0","volume":"385","author":"GE Hardingham","year":"1997","unstructured":"Hardingham GE, Chawla S, Johnson CM, Bading H (1997) Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385:260\u2013265","journal-title":"Nature"},{"key":"9053_CR112","doi-asserted-by":"crossref","first-page":"13217","DOI":"10.1073\/pnas.172504199","volume":"99","author":"OV Vitolo","year":"2002","unstructured":"Vitolo OV, Sant\u2019Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M (2002) Amyloid beta-peptide inhibition of the PKA\/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A 99:13217\u201313221","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9053_CR113","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bbrc.2010.12.048","volume":"404","author":"XY Li","year":"2011","unstructured":"Li XY, Zhan XR, Liu XM, Wang XC (2011) CREB is a regulatory target for the protein kinase Akt\/PKB in the differentiation of pancreatic ductal cells into islet beta-cells mediated by hepatocyte growth factor. Biochem Biophys Res Commun 404:711\u2013716","journal-title":"Biochem Biophys Res Commun"},{"key":"9053_CR114","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1007\/s11064-012-0860-8","volume":"37","author":"S Arlt","year":"2012","unstructured":"Arlt S, M\u00fcller-Thomsen TM, Beisiegel U, Kontush A (2012) Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer\u2019s disease. Neurochem Res 37:2706\u20132714","journal-title":"Neurochem Res"},{"key":"9053_CR115","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneurol.2012.85","volume":"69","author":"DR Galasko","year":"2012","unstructured":"Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG et al (2012) Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol 69:836\u2013841","journal-title":"Arch Neurol"},{"key":"9053_CR116","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1152\/ajpheart.00448.2003","volume":"285","author":"Z Bagi","year":"2003","unstructured":"Bagi Z, Cseko C, Toth E, Koller A (2003) Oxidative stress-induced dysregulation of arteriolar wall shear stress and blood pressure in hyperhomocysteinemia is prevented by chronic vitamin C treatment. Am J Physiol Heart Circ Physiol 285:2277\u20132283","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9053_CR117","first-page":"402","volume":"58","author":"A Nadeau","year":"1988","unstructured":"Nadeau A, Roberge AG (1988) Effects of vitamin B12 supplementation on choline acetyltransferase activity in cat brain. Int J Vitam Nutr Res 58:402\u2013406","journal-title":"Int J Vitam Nutr Res"},{"key":"9053_CR118","first-page":"426","volume":"14","author":"T Ikeda","year":"1992","unstructured":"Ikeda T, Yamamoto K, Takahashi K (1992) Treatment of Alzheimer-type dementia with intravenous methylcobalamin. Clin Ther 14:426\u2013437","journal-title":"Clin Ther"},{"key":"9053_CR119","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","volume":"336","author":"M Sano","year":"1997","unstructured":"Sano M, Ernesto C, Thomas RG et al (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer\u2019s disease. N Engl J Med 336:1216\u20131222","journal-title":"N Engl J Med"},{"key":"9053_CR120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1096\/fj.03-0961fje","volume":"18","author":"S Sung","year":"2004","unstructured":"Sung S, Yao Y, Uryu K et al (2004) Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer\u2019s disease. FASEB J 18:323\u2013325","journal-title":"FASEB J"},{"key":"9053_CR121","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.freeradbiomed.2004.04.037","volume":"37","author":"H Nakashima","year":"2004","unstructured":"Nakashima H, Ishihara T, Yokota O et al (2004) Effects of \u03b1-tocopherol on an animal model of tauopathies. Free Radic Biol Med 37:176\u2013186","journal-title":"Free Radic Biol Med"},{"key":"9053_CR122","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI28769","volume":"117","author":"D Dias-Santagata","year":"2007","unstructured":"Dias-Santagata D, Fulga TA, Duttaroy A, Feany MB (2007) Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J Clin Investig 117:236\u2013245","journal-title":"J Clin Investig"},{"key":"9053_CR123","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1159\/000255105","volume":"28","author":"VN Pavlik","year":"2009","unstructured":"Pavlik VN, Doody RS, Rountree SD, Darby EJ (2009) Vitamin E use is associated with improved survival in an Alzheimer\u2019s disease cohort. Dement Geriatr Cogn Disord 28:536\u2013540","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9053_CR124","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/cbdd.12282","volume":"83","author":"ML Bolognesi","year":"2014","unstructured":"Bolognesi ML, Bergamini C, Fato R, Oiry J, Vasseur JJ, Smietana M (2014) Synthesis of new lipoic acid conjugates and evaluation of their free radical scavenging and neuroprotective activities. Chem Biol Drug Des 83:688\u2013696","journal-title":"Chem Biol Drug Des"},{"key":"9053_CR125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/jcbfm.2013.196","volume":"34","author":"H Sancheti","year":"2014","unstructured":"Sancheti H, Kanamori K, Patil I, D\u00edaz Brinton R, Ross BD, Cadenas E (2014) Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer\u2019s disease: a 13C NMR study. J Cereb Blood Flow Metab 34:288\u2013296","journal-title":"J Cereb Blood Flow Metab"},{"key":"9053_CR126","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12603-013-0004-0","volume":"17","author":"RJ Kryscio","year":"2013","unstructured":"Kryscio RJ, Abner EL, Schmitt FA et al (2013) A randomized controlled Alzheimer\u2019s disease prevention trial\u2019s evolution into an exposure trial: the PREADViSE trial. J Nutr Health Aging 17:72\u201375","journal-title":"J Nutr Health Aging"},{"key":"9053_CR127","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1523\/JNEUROSCI.0482-06.2006","volume":"26","author":"L Esposito","year":"2006","unstructured":"Esposito L, Raber J, Kekonius L et al (2006) Reduction in mitochondrial superoxide dismutase modulates Alzheimer\u2019s disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci 26:5167\u20135179","journal-title":"J Neurosci"},{"key":"9053_CR128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejphar.2013.04.033","volume":"715","author":"N Rajasekar","year":"2013","unstructured":"Rajasekar N, Dwivedi S, Tota SK, Kamat PK, Hanif K, Nath C, Shukla R (2013) Neuroprotective effect of curcumin on okadaic acid induced memory impairment in mice. Eur J Pharmacol 715:381\u2013394","journal-title":"Eur J Pharmacol"},{"key":"9053_CR129","doi-asserted-by":"crossref","unstructured":"Ringman M, Cole GM, Tend E (2008) Oral curcumin for the treatment of mild-to-moderate Alzheimer\u2019s disease: tolerability and clinical and biomarker efficacy results of a placebo-controlled 24-week study. Proceedings of the International Conference of Alzheimer\u2019s disease Chicago, abstract.","DOI":"10.1016\/j.jalz.2008.05.2414"},{"key":"9053_CR130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1533317508325094","volume":"24","author":"R Remington","year":"2009","unstructured":"Remington R, Chan A, Paskavitz J, Shea TB (2009) Efficacy of a vitamin\/nutriceutical formulation for moderate-stage to later-stage Alzheimer\u2019s disease: a placebo-controlled pilot study. Am J Alzheimers Dis Other Demen 24:27\u201333","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"9053_CR131","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12603-010-0054-5","volume":"14","author":"A Chan","year":"2010","unstructured":"Chan A, Remington R, Kotyla E, Lepore A, Zemianek J, Shea TB (2010) A vitamin\/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia. J Nutr Health Aging 14:224\u2013230","journal-title":"J Nutr Health Aging"},{"key":"9053_CR132","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-3-7091-7508-8_30","volume":"54","author":"H Gutzmann","year":"1998","unstructured":"Gutzmann H, Hadler D (1998) Sustained efficacy and safety of idebenone in the treatment of Alzheimer\u2019s disease: update on a two-year double-blind multicentre study. J Neural Transm Suppl 54:301\u2013310","journal-title":"J Neural Transm Suppl"},{"key":"9053_CR133","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1212\/01.WNL.0000096376.03678.C1","volume":"61","author":"LJ Thal","year":"2003","unstructured":"Thal LJ, Grundman M, Berg J, Ernstrom K, Margolin R, Pfeiffer E, Weiner MFF, Zamrini E, Thomas RG (2003) Idebenone treatment fails to slow cognitive decline in Alzheimer\u2019s disease. Neurology 61:1498\u20131502","journal-title":"Neurology"},{"key":"9053_CR134","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000119366","volume":"36","author":"G Weyer","year":"1997","unstructured":"Weyer G, Babej-D\u00f6lle RM, Hadler D, Hoffmann S, Hermann WM (1997) A controlled study of 2 doses of idebenone in the treatment of Alzheimer\u2019s disease. Neuropsychobiology 36:73\u201382","journal-title":"Neuropsychobiology"},{"key":"9053_CR135","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jama.283.8.1007","volume":"283","author":"RA Mulnard","year":"2000","unstructured":"Mulnard RA, Cotman CW, Kawas C et al (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. J Am Med Assoc 283:1007\u20131015","journal-title":"J Am Med Assoc"},{"key":"9053_CR136","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10571-010-9631-8","volume":"31","author":"S Singh","year":"2011","unstructured":"Singh S, Thakur MK (2011) Gonadal steroids do not affect apolipoprotein E expression in aging mouse cerebral cortex. Cell Mol Neurobiol 31:401\u2013405","journal-title":"Cell Mol Neurobiol"},{"key":"9053_CR137","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1385\/JMN:20:2:125","volume":"20","author":"I Boldogh","year":"2003","unstructured":"Boldogh I, Liebenthal D, Hughes TK et al (2003) Modulation of 4HNE-mediated signaling by proline-rich peptides from ovine colostrum. J Mol Neurosci 20:125\u2013134","journal-title":"J Mol Neurosci"},{"key":"9053_CR138","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00005-012-0187-9","volume":"60","author":"A Zab\u0142ocka","year":"2012","unstructured":"Zab\u0142ocka A, Janusz M (2012) Effect of the proline-rich polypeptide complex\/colostrininTM on the enzymatic antioxidant system. Arch Immunol Ther Exp 60:383\u2013390","journal-title":"Arch Immunol Ther Exp"},{"key":"9053_CR139","first-page":"I93","volume":"8","author":"J Leszek","year":"2002","unstructured":"Leszek J, Inglot AD, Janusz M et al (2002) Colostrinin proline-rich polypeptide complex fromovine colostrum\u2014a long-term study of its efficacy in Alzheimer\u2019s disease. Med Sci Monit 8:I93\u2013I96","journal-title":"Med Sci Monit"},{"key":"9053_CR140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-2004-6103","volume":"6","author":"A Bilikiewicz","year":"2004","unstructured":"Bilikiewicz A, Gaus W (2004) Colostrinin1 (a naturally occurring proline-rich, polypeptide mixture) in the treatment of Alzheimer\u2019s disease. J Alzheimers Dis 6:17\u201326","journal-title":"J Alzheimers Dis"},{"key":"9053_CR141","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11010-013-1675-x","volume":"380","author":"N Jia","year":"2013","unstructured":"Jia N, Han K, Kong JJ, Zhang XM, Sha S, Ren GR, Cao YP (2013) (\u2212)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP\/PS1 mice by restoring IRS-1 signaling defects in the hippocampus. Mol Cell Biochem 380:211\u2013218","journal-title":"Mol Cell Biochem"},{"key":"9053_CR142","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejmech.2013.10.068","volume":"71","author":"SY Li","year":"2014","unstructured":"Li SY, Wang XB, Kong LY (2014) Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer\u2019s disease. Eur J Med Chem 71:36\u201345","journal-title":"Eur J Med Chem"},{"key":"9053_CR143","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1021\/jm400567s","volume":"56","author":"C Lu","year":"2013","unstructured":"Lu C, Guo Y, Yan J, Luo Z, Luo HB, Yan M, Huang L, Li X (2013) Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer\u2019s disease. J Med Chem 56:5843\u20135859","journal-title":"J Med Chem"},{"key":"9053_CR144","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/alzrt49","volume":"2","author":"RW Jones","year":"2010","unstructured":"Jones RW (2010) Dimebon disappointment. Alzheimers Res Ther 2:25","journal-title":"Alzheimers Res Ther"},{"key":"9053_CR145","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4161\/auto.23487","volume":"9","author":"JW Steele","year":"2013","unstructured":"Steele JW, Gandy S (2013) Latrepirdine (Dimebon\u00ae), a potential Alzheimer therapeutic, regulates autophagy and neuropathology in an Alzheimer mouse model. Autophagy 9:617\u2013818","journal-title":"Autophagy"},{"key":"9053_CR146","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1038\/tp.2013.97","volume":"3","author":"PR Bharadwaj","year":"2013","unstructured":"Bharadwaj PR, Bates KA, Porter T, Teimouri E, Perry G, Steele JW, Gandy S, Groth D, Martins RN, Verdile G (2013) Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer\u2019s and other neurodegenerative diseases. Transl Psychiatry 3:e332","journal-title":"Transl Psychiatry"},{"key":"9053_CR147","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/JAD-130722","volume":"38","author":"L Shinto","year":"2014","unstructured":"Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J (2014) A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer\u2019s disease. J Alzheimers Dis 38:111\u2013120","journal-title":"J Alzheimers Dis"},{"key":"9053_CR148","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.redox.2013.01.002","volume":"1","author":"SS Hardas","year":"2013","unstructured":"Hardas SS, Sultana R, Clark AM, Beckett TL, Szweda LI, Murphy MP, Butterfield DA (2013) Oxidative modification of lipoic acid by HNE in Alzheimer disease brain. Redox Biol 1:80\u201385","journal-title":"Redox Biol"},{"key":"9053_CR149","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neurobiolaging.2005.12.014","volume":"28","author":"JF Quinn","year":"2007","unstructured":"Quinn JF, Bussiere JR, Hammond RS et al (2007) Chronic dietary \u03b1-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol Aging 28:213\u2013225","journal-title":"Neurobiol Aging"},{"key":"9053_CR150","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1476-5381.2009.00295.x","volume":"157","author":"P Lu","year":"2009","unstructured":"Lu P, Mamiya T, Lu LL et al (2009) Silibinin prevents amyloid b peptide-induced memory impairment and oxidative stress in mice. Br J Pharmacol 157:1270\u20131277","journal-title":"Br J Pharmacol"},{"key":"9053_CR151","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbr.2011.02.041","volume":"221","author":"S Tota","year":"2011","unstructured":"Tota S, Kamat PK, Shukla R, Nath C (2011) Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment. Behav Brain Res 221:207\u2013215","journal-title":"Behav Brain Res"},{"key":"9053_CR152","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbr.2010.01.017","volume":"209","author":"S Tota","year":"2010","unstructured":"Tota S, Awasthi H, Kamat PK, Nath C, Hanif K (2010) Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav Brain Res 209:73\u201379","journal-title":"Behav Brain Res"},{"key":"9053_CR153","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.freeradbiomed.2004.08.023","volume":"37","author":"Z Feng","year":"2004","unstructured":"Feng Z, Zhang JT (2004) Protective effect of melatonin on \u03b2-amyloid-induced apoptosis in rat astroglioma c6 cells and its mechanism. Free Radic Biol Med 37:1790\u20131801","journal-title":"Free Radic Biol Med"},{"key":"9053_CR154","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1471-4159.2003.01654.x","volume":"85","author":"E Matsubara","year":"2003","unstructured":"Matsubara E, Bryant-Thomas T, Quinto JP et al (2003) Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer\u2019s disease. J Neurochem 85:1101\u20131108","journal-title":"J Neurochem"},{"key":"9053_CR155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.pbb.2009.09.022","volume":"94","author":"G Saxena","year":"2010","unstructured":"Saxena G, Bharti S, Kamat PK, Sharma S, Nath C (2010) Melatonin alleviates memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats. Pharmacol Biochem Behav 94:397\u2013403","journal-title":"Pharmacol Biochem Behav"},{"key":"9053_CR156","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.freeradbiomed.2010.07.007","volume":"49","author":"JRP Prasanthi","year":"2010","unstructured":"Prasanthi JRP, Dasari B, Marwarha G et al (2010) Caffeine protects against oxidative stress and Alzheimer\u2019s disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med 49:1212\u20131220","journal-title":"Free Radic Biol Med"},{"key":"9053_CR157","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2174\/156720508785132271","volume":"5","author":"S Andrieu","year":"2008","unstructured":"Andrieu S, Ousset PJ, Coley N, Ouzid M, Mathiex-Fortunet H, Vellas B, The GuidAge study Group (2008) GuidAge study: a 5-year double-blind, randomized trial of EGb761 for the prevention of Alzheimer\u2019s disease in elderly subjects with memory complaints rationale, design and baseline data. Curr Alzheimer Res 5:406\u2013415","journal-title":"Curr Alzheimer Res"},{"key":"9053_CR158","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1474-4422(12)70206-5","volume":"11","author":"B Vellas","year":"2012","unstructured":"Vellas B, Coley N, Ousset PJ et al (2012) Long-term use of standardized ginkgo biloba extract for the prevention of Alzheimer\u2019 disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 11:851\u2013859","journal-title":"Lancet Neurol"},{"key":"9053_CR159","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.2009.1913","volume":"302","author":"BE Snitz","year":"2009","unstructured":"Snitz BE, O\u2019Meara ES, Carlson MC, Arnold AM, Ives DG, Rapp SR, Saxton J, Lopez OL, Dunn LO, Sink KM, DeKosky ST, Ginkgo Evaluation of Memory (GEM) Study Investigators (2009) Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 302:2663\u20132670","journal-title":"JAMA"},{"key":"9053_CR160","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.pbb.2007.03.010","volume":"86","author":"G Saxena","year":"2007","unstructured":"Saxena G, Singh SP, Pal R, Singh S, Pratap R, Nath C (2007) Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice. Pharmacol Biochem Behav 86:797\u2013805","journal-title":"Pharmacol Biochem Behav"},{"key":"9053_CR161","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jep.2009.12.012","volume":"127","author":"R Niranjan","year":"2010","unstructured":"Niranjan R, Kamat PK, Nath C, Shukla R (2010) Evaluation of guggulipid and nimesulide on production of inflammatory mediators and GFAP expression in LPS stimulated rat astrocytoma, cell line (C6). J Ethnopharmacol 127:625\u2013630","journal-title":"J Ethnopharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-9053-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-014-9053-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-9053-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-9053-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T12:24:32Z","timestamp":1650803072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-014-9053-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,17]]},"references-count":161,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["9053"],"URL":"https:\/\/doi.org\/10.1007\/s12035-014-9053-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,17]]}}}